Compared to other organs, murine cytomegalovirus (MCMV) replication in the salivary gland is uniquely resistant to CD8 T-cell control. The contribution of viral genes that interfere with antigen presentation (VIPRs) to this resistance was assessed using a mutant lacking MCMV's known VIPRs. Salivary gland titers of the VIPR-deficient virus were at least 10-fold lower than those of the wild type during the persistent phase of infection; the defect was reversed by depleting CD8 T cells. Thus, VIPRs contribute to CD8 T cells' inability to control virus in the salivary gland.
Cytomegaloviruses (CMVs) are ubiquitous, species-specific members of the beta subfamily of herpesviruses. They establish asymptomatic, lifelong infection of the immunocompetent host but can cause severe or fatal infection in the immunocompromised. Experimental infection of mice with murine CMV (MCMV) is widely used to explore the relationship between this highly successful pathogen and its hosts (14) . MCMV infection is characterized by three phases. Acute infection of central visceral organs is rapidly controlled but is followed by persistent infection of the salivary gland for several weeks. Finally, latent infection is established for the life of the host.
Previous studies have revealed a unique pattern of immune control of MCMV in the salivary gland (9, 10) . CD8 T cells are able to eliminate replicating virus from all central organs and from salivary gland fibroblasts. However, virus replicating in salivary gland acinar epithelial cells is resistant to CD8 T-cell control, and CD4 T cells secreting gamma interferon (IFN-␥) are required to control salivary gland infection (12) . Since acinar epithelial cells are responsible for the majority of virus production in the salivary gland, CD8 T-cell depletion has little or no impact on salivary gland virus titers. The reason for CD8 T cells' impotence in this site is not clear. A recent, detailed study of the immunological milieu of the MCMV-infected salivary gland showed that CD8 T cells are recruited there in large numbers and that they remain highly functional, readily lysing MCMV-infected fibroblasts and secreting IFN-␥ in response to antigen directly ex vivo (1) . Furthermore, the infected salivary gland contained high levels of IFN-␥, which should promote CD8 T-cell recognition. Because CD8 T cells can control virus in other sites but not in salivary gland acinar epithelial cells, it has been suggested that these cells may be peculiarly resistant to the antiviral actions of CD8 T cells (1) .
We began to study the salivary gland in an attempt to understand the biological significance of MCMV's genes that interfere with antigen presentation to CD8 T cells. We have called genes with this function "VIPRs" (18) to distinguish them from other types of immunoevasins. MCMV has three VIPRs: m4, m6, and m152 (13, 14) . Together, these genes profoundly impair CD8 T-cell lysis of MCMV-infected cells in vitro (2) . In vivo, m152 was shown to have a profound impact on the ability of adoptively transferred CD8 T cells specific for a D b -restricted epitope to control virus replication in the lungs in a bone marrow transplantation model (7) . However, the impact of these genes on the course of acute infection of immunocompetent animals is more modest. While m152 has been shown to have some CD8 T-cell-dependent impact on acute virus titers in neonatal BALB/c mice (11) , no significant impact of the VIPRs was seen on acute infection in adult C57BL/6 mice (2). All herpesviruses appear to include VIPRs, suggesting that interference with CD8 T cells is important for some aspect of the herpesvirus lifestyle (15) . We had originally thought that VIPRs would be necessary for herpesviruses to maintain lifelong infection of their hosts in the face of a primed immune response. However, a virus lacking m4, m6, and m152 was unimpaired in its ability to establish latent infection in C57BL/6 mice (2). Furthermore, judged by the ongoing, active immune response, the pattern of lifelong colonization of the host was similar for wild-type and VIPR-deficient viruses in both C57BL/6 (2) and BALB/c (6) mice. Since interference with antigen presentation to CD8 T cells was not necessary for MCMV's ability to establish and maintain latent infection, we postulated that it might be necessary to enable the virus to replicate to high titers in the salivary gland in the presence of fully primed CD8 T cells.
To investigate whether MCMV's VIPRs contribute to the unique resistance of the salivary gland to CD8 T-cell control, we decided to compare infection of BALB/c mice with MCMV lacking m4, m6, and m152 (⌬m4ϩm6ϩm152) (16) and infection with its parental BAC-derived virus (MW97.01) (17). These viruses have been shown to grow equivalently in vivo in immunodepleted mice (16) . The CD8 T-cell response to MCMV in BALB/c mice is dominated by two specificities, an L d -restricted epitope from the IE1 protein (pp89) and a K drestricted epitope from m164 (8) . Since T cells specific for each of these epitopes have been shown to recognize wildtype virus-infected cells, particularly when targets are pretreated with IFN-␥ (3-5), we first wanted to determine whether the VIPRs had any impact on the presentation of these epitopes. Short-term polyclonal T-cell lines were generated against m164 and pp89 by peptide stimulation of splenocytes from an infected BALB/c mouse and used 11 days later in a standard Cr release assay in the presence or absence of IFN-␥. Figure 1 shows that both pp89-specific and m164-specific cytotoxic T-lymphocyte (CTL) lines readily lysed fibroblasts infected with ⌬m4ϩm6ϩm152, with or without IFN-␥ pretreatment. The m164-specific CTL line showed some ability to lyse wild-type virus-infected cells that had been pretreated with IFN-␥. However, in all circumstances, ⌬m4ϩm6ϩm152-infected cells were much more susceptible to CTL than were wild-type-infected cells. Thus, there was a significant quantitative difference in the ability of CD8 T cells to detect the two viruses.
We next infected BALB/c mice with either wild-type or ⌬m4ϩm6ϩm152 MCMV. Mice were sacrificed at various times postinfection, and virus titers in the salivary gland were determined by a standard PFU assay. Figure 2 (A and B) shows the results of two experiments. MCMV was first detected in the salivary gland at 1 week postinfection, at which time there was no significant difference between wild-type and ⌬m4ϩm6ϩm152 virus. At day 14 and all later time points, wild-type virus reached titers that were at least 1 log higher than those of ⌬m4ϩm6ϩm152. These experiments were performed using tissue culture (tc)-prepared virus stocks. To determine whether this difference would persist after tissue adaptation of the viruses, we generated salivary gland stocks from mice infected with tc virus in the experiment shown in Fig. 2C (left side) . Naïve mice were then infected with 1.5 ϫ 10 3 PFU of these stocks, and salivary gland titers were assessed 16 days later (Fig. 2C, right side) . Again, wild-type virus titers were more than a log higher than those of ⌬m4ϩm6ϩm152.
To confirm that the defect in ⌬m4ϩm6ϩm152's ability to grow in the salivary gland was due to CD8 T-cell control and not due to an unrecognized mutation elsewhere in the genome, we determined whether CD8 T-cell depletion could eliminate the difference between wild-type and ⌬m4ϩm6ϩm15 viruses. Mice were depleted of CD8 T cells using two monoclonal antibodies directed against the beta chain of CD8. Figure 3 shows that, as previously described, CD8 T-cell depletion did not affect the salivary gland titers of wild-type virus. However, in CD8 T-cell-deficient animals, ⌬m4ϩm6ϩm152 achieved the same titers in the salivary gland as wild-type MCMV did. Thus, the defect in ⌬m4ϩm6ϩm152 growth in the salivary gland is caused by increased susceptibility to CD8 T-cell control.
These results indicate that MCMV in the salivary gland is not intrinsically resistant to the antiviral effects of CD8 T cells. Rather, MCMV's VIPRs apparently act more efficiently in the salivary gland, contributing to the result that CD8 T cells have no impact at this site when they are able to control virus in other organs. We note, however, that even when the VIPRs were removed, CD8 T cells did not rapidly eradicate the virus from the FIG. 1. Impact of MCMV's VIPRs on CTL lysis of cells infected with wild-type or ⌬m04ϩm06ϩm152 MCMV. Polyclonal CTL lines were treated by stimulating splenocytes with 10 Ϫ9 M pp89 or m164 peptide and cultured for 11 days; interleukin-2 (10 U/ml) was added after day 3. BALB/c MEFs were treated with 50 U/ml IFN-␥ for 24 h and then infected with the indicated virus (multiplicity of infection, 20) in the presence of phosphonoacetic acid or pulsed with peptide (10 Ϫ6 M) before use in a Cr release assay as previously described (2) . Graphs show means Ϯ standard deviations of triplicate wells. E:T, effector-totarget cell ratio. (C) Mice were infected with 10 6 PFU of tc virus stock, and salivary glands were harvested on day 21 (tc virus). The salivary glands from mice infected with each virus were pooled, yielding salivary gland stock of 1.2 ϫ10 5 PFU/ml for wild type and 2.6 ϫ 10 4 PFU/ml for ⌬m4ϩm6ϩ m152 MCMV. Mice (n ϭ 5 per group) were infected with 1.5 ϫ 10 3 PFU of this salivary gland stock, and virus titers in the salivary glands were determined at day 16 postinfection.
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NOTES 4201 salivary gland. Rather, their impact was limited to reducing virus titers. Thus, additional factors, either viral or host encoded, may be involved in the resistance of salivary gland virus to CD8 T-cell control. However, these results suggest that MCMV's VIPRs contribute to the ability of the virus to achieve sufficient titers in the salivary gland for transmission to new hosts after the adaptive immune response has developed.
FIG. 3. CD8 T-cell depletion restores growth of ⌬m4ϩm6ϩm152 in the salivary gland to wild-type levels. BALB/c mice were injected intraperitoneally with two monoclonal antibodies against CD8-ß (100 g 53.5.8, a gift from David Parker, and 100 g YTS156, a gift from Sophie Sierro) on days Ϫ3 and Ϫ1 before infection. Control mice were injected with 200 g rat immunoglobulin G (IgG; Sigma). On day 0, five mice per group were infected with 1 ϫ 10 5 PFU of wild-type or ⌬m4ϩm6ϩm152 MCMV. Fluorescence-activated cell sorting analysis of two mice showed that CD8 T-cell depletion in the blood was Ͼ98% on days 0 and 7 postinfection (data not shown). Mice were sacrificed at day 14 postinfection, and salivary gland virus titers were determined. Circles represent individual animals, and the line shows the mean titer. P values were determined by Student's t test. Two experiments have been performed with similar results.
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